Not a traditional drug phase: Cyclic Sighing Breathing Exercise for Transurethral Resection of Bladder Tumor
Transurethral resection (TUR) is a common minimally invasive surgical procedure for lower urinary tract diseases. However, postoperative urinary catheterization often causes catheter-related bladder discomfort (CRBD) and pain due to bladder spasms, which negatively impact recovery and sleep quality.
Official registry: https://clinicaltrials.gov/study/NCT07843602 · Mersin University · enrollment listed as 76
What this phase means
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
If you join, the listed intervention(s) are Cyclic Sighing Breathing Exercise. The registry lists allocation as randomized. Transurethral resection (TUR) is a common minimally invasive surgical procedure for lower urinary tract diseases.
They plan to enroll about 76 people at 2 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
The Effect of Cyclic Sighing Breathing Exercise on Catheter-Related Bladder Discomfort, Pain, and Sleep Quality in Patients Undergoing Transurethral Resection: A Randomized Controlled Trial
Interventions: Cyclic Sighing Breathing Exercise
Primary outcome (registry wording): Catheter-Related Bladder Discomfort (CRBD) Severity Score
Who it is for (from inclusion criteria)
- Ages 18 Years to any
- Aged 18 years or older
- Undergoing Transurethral Resection of the Prostate (TUR-P) or Transurethral Resection of Bladder Tumor (TUR-M/TUR-BT)
- Having an indwelling urethral catheter placed postoperatively
- Fully conscious, oriented, and cooperative
- Able to speak and understand Turkish
Who the registry excludes
- American Society of Anesthesiologists (ASA) physical status score of IV or higher
- Presence of any medical condition or physical impairment that prevents performing breathing exercises
- Diagnosed history of sleep apnea
- Regular use of sedative, hypnotic, or sleep-inducing medications
- Neurological or psychiatric disorders severely impeding hearing, vision, or verbal communication
- Refusal to participate in the study
Public study contact (from the registry)
Hasan Şeren
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
2 listed- Hatay Iskenderun State Hospital — Hatay, Turkey (Türkiye) (not_yet_recruiting)
- Iskenderun State Hospital — Hatay, Turkey (Türkiye) (recruiting)
FAQ about this NCT record
Is NCT07843602 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT07843602?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT07843602?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary